Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biophytis (BPTSY)
OTHER OTC:BPTSY
Holding BPTSY?
Track your performance easily
BPTSY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.24 - $39.16
Previous Close$3.32
Volume119.00
Average Volume (3M)681.00
Market Cap
$1.72M
Enterprise Value-$5.56M
Total Cash (Recent Filing)€5.57M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)0.0
Beta0.95
Next Earnings
Feb 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15420.51
Shares Outstanding286,504
10 Day Avg. Volume232
30 Day Avg. Volume681
Standard Deviation0.16
R-Squared0.11
Alpha-0.15
Financial Highlights & Ratios
Price to Book (P/B)-0.24
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biophytis News
PremiumCompany Announcements
Biophytis Advances Clinical Trials and Targets $100B Market
PremiumCompany Announcements
Biophytis Advances DMD Treatment with BIO101 Scale-UpRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BPTSY FAQ
What was Biophytis’s price range in the past 12 months?
Biophytis lowest stock price was $3.24 and its highest was $39.16 in the past 12 months.
What is Biophytis’s market cap?
Currently, no data Available
When is Biophytis’s upcoming earnings report date?
Biophytis’s upcoming earnings report date is Feb 24, 2025 which is in 116 days.
How were Biophytis’s earnings last quarter?
Biophytis released its earnings results on Sep 30, 2024. The company reported -$17.949 earnings per share for the quarter, missing the consensus estimate of -$2.16 by -$15.789.
Is Biophytis overvalued?
According to Wall Street analysts Biophytis’s price is currently Overvalued.
Does Biophytis pay dividends?
Biophytis does not currently pay dividends.
What is Biophytis’s EPS estimate?
Biophytis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biophytis have?
Biophytis has 351,174 shares outstanding.
What happened to Biophytis’s price movement after its last earnings report?
Biophytis reported an EPS of -$17.949 in its last earnings report, missing expectations of -$2.16. Following the earnings report the stock price went down -0.673%.
Which hedge fund is a major shareholder of Biophytis?
Currently, no hedge funds are holding shares in BPTSY
---
Biophytis Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-89.48%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-41.42%
Trailing 12-Months
Company Description
Biophytis
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases.
---
BPTSY Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Advaxis
―
Cyclacel Pharmaceuticals
―
Plus Therapeutics
―
TRACON Pharmaceuticals
―
Sanofi
―
Best Analysts Covering BPTSY
1 Year
1 Year Success Rate
0/5 ratings generated profit
1 Year Average Return
-69.46%
reiterated a buy rating 4 months ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -69.46% per trade.
---